Casdin Capital, LLC, along with its affiliated entities, reported the sale of 1.2 million shares of BioLife Solutions Inc. (NASDAQ:BLFS) common stock, totaling $28.1 million over three days from May 19 to May 21, 2026. The shares were sold at prices ranging from $22.65 to $23.70, with the stock currently trading at $24.75, reflecting a 17.5% gain over the past week. Following these transactions, Casdin entities now hold 4,757,165 shares of BioLife Solutions. In addition to the stock sales, BioLife Solutions announced its Q1 2026 earnings, reporting revenue of $27.5 million, which exceeded analyst forecasts of $25.68 million by 7.09%. The earnings per share (EPS) remained stable at $0.02, aligning with expectations. BioLife Solutions has a market capitalization of $1.2 billion and a beta of 1.97, indicating notable volatility. The strong earnings report has positively influenced investor sentiment, reflecting growing confidence in the company's performance.